OWKIN and 10x Genomics, Inc. announced they have entered into an agreement to add 10x Genomics spatial omics and single-cell technologies to the ambitious MOSAIC project, which has already garnered attention for its pioneering work in tumor analysis for therapeutic discovery. Unveiled in June 2023, MOSAIC is a landmark $50 million project that leverages spatial omics technologies to map tumor structures at single-cell resolution, encompassing an astounding 7,000 tumor samples?100 times larger than any comparable dataset. With the addition of 10x Genomics' Visium technology for spatial transcriptomics and leading Chromium portfolio for single-cell analysis, MOSAIC is poised to unlock transformative discoveries in the battle against cancer, unveiling unprecedented insights into tumor and immune cell interactions.